咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >肝纤维化治疗:从传统方法到纳米材料递送系统 收藏

肝纤维化治疗:从传统方法到纳米材料递送系统

Therapy of liver fibrosis:From conventional approaches to nanomaterials delivery systems

作     者:陈琳 段禹 姜婷婷 毛春 朱新华 万密密 Lin Chen;Yu Duan;Tingting Jiang;Chun Mao;Xinhua Zhu;Mimi Wan

作者机构:National and Local Joint Engineering Research Center of Biomedical Functional MaterialsSchool of Chemistry and Materials ScienceNanjing Normal UniversityNanjing 210023China Department of Hepatobiliary SurgeryAffiliated Drum Tower HospitalMedical School of Nanjing UniversityNanjing 210093China 

出 版 物:《Science Bulletin》 (科学通报(英文版))

年 卷 期:2024年第69卷第12期

页      面:1829-1832页

核心收录:

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基  金:supported by the National Natural Science Foundation of China(22175096 and 22275095) Jiangsu Key Laboratory of Biofunctional Materials,Jiangsu Collaborative Innovation Center of Biomedical Functional Materials the Qinglan Project Foundation of Colleges and Universities of Jiangsu Province 

主  题:递送系统 mortality Liver 

摘      要:Liver diseases seriously affect human *** dysfunction-associated steatohepatitis(MASH)is a highly prevalent chronic liver disease that has a global prevalence of 32.4%,but this is increasing at an alarming rate[1].Cirrhosis is the 11th most common cause of death worldwide,and there was a 47%increase in mortality between 2010 and 2021[2].

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分